Dr. Luca Santarelli, M.D., has been Chief Executive Officer of TherAchon SAS since January 5, 2017. Dr. Santarelli serves as a Venture Partner at Versant Ventures, Inc. At Versant Ventures, he plays operating or board roles in select portfolio companies and works to identify new biotech investment opportunities. He has over 20 years of experience in academic, industrial research and development and business experience. Dr. Santarelli was a Senior Vice President and Global Head of Neuroscience, Ophthalmology and Rare Diseases at Roche. In this capacity, he built a multi-disciplinary team and led efforts spanning from drug discovery to early development. Dr. Santarelli has operating experience from his progressive leadership responsibilities at Roche. He also provided strategic and operational leadership for many of the Roche external biotech collaborations and helped instill a more entrepreneurial culture in the broader R&D organization. He has been a Director of TherAchon SAS since January 5, 2017 He is a Discovery Scientist and Clinician. Dr. Santarelli received his medical and scientific training at the University of Turin and Post-Doctorate training at Columbia University where he also co-founded a venture backed startup while on faculty

 Neuroscience, Rare Disesase, Ophthalmology, Research, Development, Business development